MASI
Price
$140.88
Change
-$3.00 (-2.09%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
7.57B
103 days until earnings call
Intraday BUY SELL Signals
STIM
Price
$1.50
Change
-$0.00 (-0.00%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
102.73M
110 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MASI vs STIM

Header iconMASI vs STIM Comparison
Open Charts MASI vs STIMBanner chart's image
Masimo
Price$140.88
Change-$3.00 (-2.09%)
Volume$8.95K
Capitalization7.57B
Neuronetics
Price$1.50
Change-$0.00 (-0.00%)
Volume$41.42K
Capitalization102.73M
MASI vs STIM Comparison Chart in %
MASI
Daily Signal:
Gain/Loss:
STIM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MASI vs. STIM commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MASI is a Hold and STIM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (MASI: $140.92 vs. STIM: $1.50)
Brand notoriety: MASI and STIM are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: MASI: 122% vs. STIM: 218%
Market capitalization -- MASI: $7.57B vs. STIM: $102.73M
MASI [@Medical/Nursing Services] is valued at $7.57B. STIM’s [@Medical/Nursing Services] market capitalization is $102.73M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $219.36B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MASI’s FA Score shows that 1 FA rating(s) are green whileSTIM’s FA Score has 0 green FA rating(s).

  • MASI’s FA Score: 1 green, 4 red.
  • STIM’s FA Score: 0 green, 5 red.
According to our system of comparison, both MASI and STIM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MASI’s TA Score shows that 4 TA indicator(s) are bullish while STIM’s TA Score has 5 bullish TA indicator(s).

  • MASI’s TA Score: 4 bullish, 4 bearish.
  • STIM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, STIM is a better buy in the short-term than MASI.

Price Growth

MASI (@Medical/Nursing Services) experienced а -5.92% price change this week, while STIM (@Medical/Nursing Services) price change was -30.56% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.47%. For the same industry, the average monthly price growth was -8.60%, and the average quarterly price growth was +8.79%.

Reported Earning Dates

MASI is expected to report earnings on Mar 03, 2026.

STIM is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Medical/Nursing Services (-5.47% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MASI($7.57B) has a higher market cap than STIM($103M). STIM YTD gains are higher at: -6.832 vs. MASI (-14.749). STIM has higher annual earnings (EBITDA): -39.31M vs. MASI (-115.8M). MASI has more cash in the bank: 150M vs. STIM (11.1M). STIM has less debt than MASI: STIM (80.7M) vs MASI (642M). MASI has higher revenues than STIM: MASI (2.15B) vs STIM (111M).
MASISTIMMASI / STIM
Capitalization7.57B103M7,349%
EBITDA-115.8M-39.31M295%
Gain YTD-14.749-6.832216%
P/E Ratio116.80N/A-
Revenue2.15B111M1,941%
Total Cash150M11.1M1,351%
Total Debt642M80.7M796%
FUNDAMENTALS RATINGS
MASI vs STIM: Fundamental Ratings
MASI
STIM
OUTLOOK RATING
1..100
1061
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
5865
P/E GROWTH RATING
1..100
13100
SEASONALITY SCORE
1..100
32n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STIM's Valuation (34) in the Medical Specialties industry is somewhat better than the same rating for MASI (90). This means that STIM’s stock grew somewhat faster than MASI’s over the last 12 months.

STIM's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MASI (100). This means that STIM’s stock grew similarly to MASI’s over the last 12 months.

MASI's SMR Rating (95) in the Medical Specialties industry is in the same range as STIM (99). This means that MASI’s stock grew similarly to STIM’s over the last 12 months.

MASI's Price Growth Rating (58) in the Medical Specialties industry is in the same range as STIM (65). This means that MASI’s stock grew similarly to STIM’s over the last 12 months.

MASI's P/E Growth Rating (13) in the Medical Specialties industry is significantly better than the same rating for STIM (100). This means that MASI’s stock grew significantly faster than STIM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MASISTIM
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
66%
Bullish Trend 16 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
MASI
Daily Signal:
Gain/Loss:
STIM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLBEX38.740.11
+0.28%
American Funds American Balanced R4
GGCIX135.16N/A
N/A
Gabelli Growth I
FKACX33.23N/A
N/A
Franklin Growth Opportunities C
NSOIX18.40N/A
N/A
North Star Opportunity I
LIRSX9.77N/A
N/A
Lord Abbett International Value R4

MASI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MASI has been loosely correlated with SYK. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MASI
1D Price
Change %
MASI100%
-2.06%
SYK - MASI
51%
Loosely correlated
+1.31%
VCYT - MASI
47%
Loosely correlated
+3.02%
ISRG - MASI
46%
Loosely correlated
+3.27%
KIDS - MASI
45%
Loosely correlated
+1.65%
BSX - MASI
45%
Loosely correlated
-2.23%
More

STIM and

Correlation & Price change

A.I.dvisor indicates that over the last year, STIM has been loosely correlated with BWAY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if STIM jumps, then BWAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
+0.33%
BWAY - STIM
34%
Loosely correlated
+2.33%
DIZTF - STIM
31%
Poorly correlated
N/A
TMCI - STIM
29%
Poorly correlated
-2.51%
MASI - STIM
29%
Poorly correlated
-2.06%
DCTH - STIM
29%
Poorly correlated
-1.62%
More